✦ LIBER ✦

A Phase II Study of Lipoplatin (Liposomal Cisplatin)/Vinorelbine Combination in HER-2/neu–Negative Metastatic Breast Cancer

✍ Scribed by Fadi S. Farhat; Sally Temraz; Joseph Kattan; Khaled Ibrahim; Nizar Bitar; Nadine Haddad; Rahif Jalloul; Hassan A. Hatoum; Ghazi Nsouli; Ali I. Shamseddine

Book ID: 113538952
Publisher: CIG Media Group, LP.
Year: 2011
Tongue: English
Weight: 335 KB
Volume: 11
Category: Article
ISSN: 1526-8209
DOI: 10.1016/j.clbc.2011.08.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

457 Preliminary results of a phase II st

457 Preliminary results of a phase II study of lipoplatin (liposomal cisplatin)–vinorelbine combination as first line treatment in HER2/neu negative metastatic breast cancer (MBC)

✍ F. Farhat; J. Kattan; K. Ibrahim; N. Bitar; N. Haddad; S. Tamraz; H. Hatoum; A. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

A phase II study of bevacizumab in combi

A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer

✍ Lin, N. U.; Seah, D. S.; Gelman, R.; Desantis, S.; Mayer, E. L.; Isakoff, S.; Di 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 258 KB

All-oral combination of vinorelbine and

All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer

✍ Hesham Tawfik, Yousri Rostom, Hesham Elghazaly 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 211 KB

A Phase II Study of Weekly Vinorelbine a

A Phase II Study of Weekly Vinorelbine and Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer

✍ Juan Lucas Bayo-Calero; José I. Mayordomo; Pedro Sánchez-Rovira; Ramón Pérez-Car 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 97 KB

Phase II study of single agent oral vino

Phase II study of single agent oral vinorelbine as first-line treatment in patients with HER-2 negative metastatic breast cancer

✍ Mansour, Maged; Mourad, Cynthia 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 244 KB

All-oral combination of oral vinorelbine

All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial

✍ Tubiana-Mathieu, N; Bougnoux, P; Becquart, D; Chan, A; Conte, P-F; Majois, F; Es 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 203 KB